News Release


More news releases by year:

2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998

Return to: 2010 News Releases

Dr. Inder Kaul Joins Asiatic Clinical Research as Independent Director

ALPHARETTA, GA, June 8, 2010 -- Dr. Inder Kaul, MD, MPH, has joined Asiatic Clinical Research (www.asiaticlinical.com; ‘Asiatic’) as an Independent Director.  

Dr Kaul brings his experience in clinical development – on both sides of the table – in drug development and CRO services. Dr. Kaul has two decades of progressive experience with small to large size companies in the product development programs of drugs, biologics and devices. He has extensive clinical experience in patient management including acute care, evaluation and testing, and knowledge of epidemiology and biostatistics.

Dr Kaul is currently the Chief Medical Officer at Waltham, MA-based Artisan Pharma. Bindhu Aravapalli, Managing Director of Asiatic said that with Dr Kaul’s guidance, Asiatic will deliver what it promises in terms of service, quality and compliance in conducting clinical trials.

“Dr. Kaul is known globally for his expertise in directing scores of clinical trials (Phase I-IV) across many therapeutic areas such as infectious diseases, immunology, cardiovascular, rheumatology, and metabolic diseases,” said Aravapalli.

Prior to joining Artisan Pharma, Dr. Kaul served as Vice President of Clinical Development, Medical and Regulatory Affairs at Oscient Pharma. His responsibilities included leading  new drug product development efforts and providing  strategic and tactical leadership in all facets of drug development for two commercial products (ANTARA® and FACTIVE®), and an investigational agent Ramoplanin (a novel glycolipodepsipeptide antibiotic).

Dr. Kaul has also held senior-level management positions at a number of well-known companies.  Some of them are: 

  • Eight years at Abt Associates Clinical Trials.  As Division Vice President – his last position there – Dr. Kaul spearheaded operations and supervised clinical contracts, including medical monitoring; 
  • Medical and Technical Research Associates: Vice-President of Clinical and Medical Affairs;
  • Searle (now Pfizer):  Served as Director of International Operations, responsible for all medical aspects related to approval of drugs;
  • Boehringer Ingelheim Pharmaceuticals, Inc.: Associate Director of Clinical Research;
  • Parexel International Corporation: Director of Medical Services;
  • Candela Laser Corporation: Launched his career in the industry with the company; managed programs for gastrointestinal/urology and dermatology. Also involved with grant proposal writing.

Dr. Kaul holds an MD in anesthesiology and an MPH in epidemiology/biostatistics from the Harvard School of Public Health.

Asiatic Clinical Research is a full-service contract research organization with a focus on Phase II - IV trials.  The company undertakes clinical trials for drugs, biologics and medical devices. It has an in-house team providing turnkey services to conduct clinical trials. Head quartered in Bangalore, India, Asiatic also has additional offices and strategic partners who are located in Alpharetta GA, Orem UT, Marbella, Spain, and Bad Nauheim, Germany. 

Return to: 2010 News Releases